drugset / Trial / NCT03255330

The Effect of Gabapentin Used as a Preemptive to the Emergence and Development Chronic Neuropathic Pain in Patients After Spinal Cord Trauma

NCT03255330 ↗

Phase 3 Withdrawn Masaryk University
RandomizedParallel-groupOpen-labelTreatment

Summary

Study of the effect of gabapentin used as a preemptive to the emergence and development chronic neuropathic pain in patients after spinal cord trauma

Timeline

Start
2017-10
Primary completion
2020-02
Completion
2020-08

Outcome

Outcome not reported

Stopped (Enrollment): “no participant enrolled”

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Unknown 1800 mg —
Comparator Tramadol Other / unclassified — —
Comparator dipyrone Unknown — —

Indications